Calidi Biotherapeutics CAO/Interim CFO Tony Kalajian resigns

Calidi Biotherapeutics, Inc.

Tony Kalajian resigned all positions on October 23, 2023.
He served as Chief Accounting Officer and interim Chief Financial Officer.
No replacement or interim successor has been announced.
No reason for resignation was disclosed in the filing.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Tony Kalajian

Chief Accounting Officer and interim Chief Financial Officer

CLDI · Calidi Biotherapeutics, Inc.

Effective: 2023-10-23
Filed: October 27, 2023, 7:59 PM ET

On October 23, 2023, Mr. Tony Kalajian resigned from all positions in Calidi Biotherapeutics, Inc., including his roles as Chief Accounting Officer and as interim Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Tony Kalajian resigned as Chief Accounting Officer and interim Chief Financial Officer at Calidi Biotherapeutics, Inc..

Action: resigned
Role: Chief Accounting Officer and interim Chief Financial Officer

Exact text from the filing

On October 23, 2023, Mr. Tony Kalajian resigned from all positions in Calidi Biotherapeutics, Inc., including his roles as Chief Accounting Officer and as interim Chief Financial Officer.

View on SEC.gov

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-038547

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.